Cargando…
Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407029/ http://dx.doi.org/10.1186/2045-7022-5-S2-P1 |
| _version_ | 1782367846941065216 |
|---|---|
| author | Lambert, Nathalie Guiddir, Tamazoust Just, Jocelyne Amat, Flore |
| author_facet | Lambert, Nathalie Guiddir, Tamazoust Just, Jocelyne Amat, Flore |
| author_sort | Lambert, Nathalie |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4407029 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44070292015-04-29 Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma Lambert, Nathalie Guiddir, Tamazoust Just, Jocelyne Amat, Flore Clin Transl Allergy Poster Presentation BioMed Central 2015-03-23 /pmc/articles/PMC4407029/ http://dx.doi.org/10.1186/2045-7022-5-S2-P1 Text en Copyright © 2015 Lambert et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Lambert, Nathalie Guiddir, Tamazoust Just, Jocelyne Amat, Flore Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| title | Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| title_full | Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| title_fullStr | Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| title_full_unstemmed | Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| title_short | Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| title_sort | pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407029/ http://dx.doi.org/10.1186/2045-7022-5-S2-P1 |
| work_keys_str_mv | AT lambertnathalie pretreatmentbyomalizumaballowsallergenspecificimmunotherapyinchildrenandyoungadultwithsevereallergicasthma AT guiddirtamazoust pretreatmentbyomalizumaballowsallergenspecificimmunotherapyinchildrenandyoungadultwithsevereallergicasthma AT justjocelyne pretreatmentbyomalizumaballowsallergenspecificimmunotherapyinchildrenandyoungadultwithsevereallergicasthma AT amatflore pretreatmentbyomalizumaballowsallergenspecificimmunotherapyinchildrenandyoungadultwithsevereallergicasthma |